{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T17:34:01Z","timestamp":1784828041622,"version":"3.55.0"},"reference-count":125,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100007446","name":"King Khalid University","doi-asserted-by":"publisher","award":["2\/480\/46"],"award-info":[{"award-number":["2\/480\/46"]}],"id":[{"id":"10.13039\/501100007446","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinica Chimica Acta"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.cca.2025.120642","type":"journal-article","created":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T06:26:39Z","timestamp":1759472799000},"page":"120642","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Non-nucleic acid biomarkers in early detection of lung cancer"],"prefix":"10.1016","volume":"579","author":[{"given":"Suresh","family":"Saravanan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ravikumar","family":"Baskar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vishwar","family":"Devendiran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natarajan Alangudi","family":"Palaniappan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mugip Rahaman Abdul","family":"Wahab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Manivannan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Safia Obaidur","family":"Rab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohd","family":"Saeed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thirunavukkarasu","family":"Palaniyandi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.cca.2025.120642_bb0005","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"issue":"21","key":"10.1016\/j.cca.2025.120642_bb0010","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph192114161","article-title":"Determining association between lung cancer mortality worldwide and risk factors using fuzzy inference modeling and random forest modelling","volume":"19","author":"Wu","year":"2022","journal-title":"Int. J. Environ. Res. Public Health"},{"issue":"4&5","key":"10.1016\/j.cca.2025.120642_bb0015","doi-asserted-by":"crossref","first-page":"598","DOI":"10.4103\/ijmr.ijmr_1821_22","article-title":"Cancer incidence estimates for 2022 & projection for 2025: result from National Cancer Registry Programme","volume":"156","author":"Sathishkumar","year":"2022","journal-title":"India. Indian J Med Res."},{"issue":"3","key":"10.1016\/j.cca.2025.120642_bb0020","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1183\/13993003.00359-2016","article-title":"Risk factors for lung cancer worldwide","volume":"48","author":"Malhotra","year":"2016","journal-title":"Eur. Respir. J."},{"issue":"4","key":"10.1016\/j.cca.2025.120642_bb0025","doi-asserted-by":"crossref","first-page":"2142","DOI":"10.15419\/bmrat.v5i4.428","article-title":"Tobacco smoking and cancer types: a review","volume":"5","author":"Khani","year":"2018","journal-title":"Biomed. Res. Ther."},{"issue":"3","key":"10.1016\/j.cca.2025.120642_bb0030","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.3390\/curroncol29030150","article-title":"Non-small-cell lung cancer in 2022: a review for general practitioners in oncology","volume":"29","author":"Mithoowani","year":"2022","journal-title":"Curr. Oncol."},{"issue":"3","key":"10.1016\/j.cca.2025.120642_bb0035","doi-asserted-by":"crossref","first-page":"288","DOI":"10.21037\/tlcr.2016.06.07","article-title":"Non-small cell lung cancer: current treatment and future advances","volume":"5","author":"Zappa","year":"2016","journal-title":"Transl. Lung Cancer Res."},{"issue":"13","key":"10.1016\/j.cca.2025.120642_bb0040","doi-asserted-by":"crossref","first-page":"3474","DOI":"10.3390\/cancers15133474","article-title":"Advances in genomic data and biomarkers: revolutionizing NSCLC diagnosis and treatment","volume":"15","author":"Restrepo","year":"2023","journal-title":"Cancers"},{"issue":"1","key":"10.1016\/j.cca.2025.120642_bb0045","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/s41572-020-00235-0","article-title":"Small-cell lung cancer","volume":"7","author":"Rudin","year":"2021","journal-title":"Nat. Rev. Dis. Primers."},{"key":"10.1016\/j.cca.2025.120642_bb0050","series-title":"StatPearls","article-title":"Small Cell Lung Cancer","author":"Basumallik","year":"2023"},{"issue":"1","key":"10.1016\/j.cca.2025.120642_bb0055","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1039\/D2LC00666A","article-title":"Tailored point-of-care biosensors for liquid biopsy in the field of oncology","volume":"23","author":"Singh","year":"2023","journal-title":"Lab Chip"},{"key":"10.1016\/j.cca.2025.120642_bb0060","first-page":"35","article-title":"Diagnostic, prognostic, and predictive biomarkers in gastric cancer: from conventional to novel biomarkers. Transl res","volume":"274","author":"Khalili-Tanha","year":"2024","journal-title":"J. Lab. Clin. Med."},{"key":"10.1016\/j.cca.2025.120642_bb0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.talanta.2019.120251","article-title":"Electrochemical biosensors for the detection of lung cancer biomarkers: a review","volume":"206","author":"Khanmohammadi","year":"2020","journal-title":"Talanta"},{"issue":"16","key":"10.1016\/j.cca.2025.120642_bb0070","doi-asserted-by":"crossref","first-page":"3923","DOI":"10.3390\/cancers13163923","article-title":"The liquid biopsy for lung cancer: state of the art, limitations and future developments","volume":"13","author":"Di Capua","year":"2021","journal-title":"Cancers"},{"issue":"3","key":"10.1016\/j.cca.2025.120642_bb0075","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1002\/ijc.33217","article-title":"Liquid biopsies: Potential and challenges","volume":"148","author":"Heidrich","year":"2021","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.cca.2025.120642_bb0080","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1007\/s00262-020-02752-z","article-title":"Immunotherapy in nonsmall-cell lung cancer: current status and future prospects for liquid biopsy","volume":"70","author":"Brozos-V\u00e1zquez","year":"2021","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.cca.2025.120642_bb0085","first-page":"107","article-title":"Detection of predictive biomarkers using liquid biopsies in predictive biomarkers in oncology: applications in precision medicine","author":"Davis","year":"2018","journal-title":"Springer International Publishing"},{"issue":"4","key":"10.1016\/j.cca.2025.120642_bb0090","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.tcb.2019.02.001","article-title":"Metastasis stemming from circulating tumour cell clusters","volume":"29","author":"Yu","year":"2019","journal-title":"Trends Cell Biol."},{"issue":"1","key":"10.1016\/j.cca.2025.120642_bb0095","first-page":"18","article-title":"Bring along your friends: homotypic and heterotypic circulating tumour cell clustering to accelerate metastasis","volume":"43","author":"Aceto","year":"2020","journal-title":"Biom. J."},{"issue":"7745","key":"10.1016\/j.cca.2025.120642_bb0100","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1038\/s41586-019-0915-y","article-title":"Neutrophils escort circulating tumour cells to enable cell cycle progression","volume":"566","author":"Szczerba","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.cca.2025.120642_bb0105","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1007\/s10549-020-05662-x","article-title":"Prognostic value of HER2 status on circulating tumour cells in advanced-stage breast cancer patients with HER2-negative tumours","volume":"181","author":"Wang","year":"2020","journal-title":"Breast Cancer Res. Treat."},{"issue":"10","key":"10.1016\/j.cca.2025.120642_bb0110","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1038\/s41388-021-01657-0","article-title":"DNA methylome profiling of circulating tumour cells in lung cancer at single base-pair resolution","volume":"40","author":"Zhao","year":"2021","journal-title":"Oncogene"},{"issue":"Suppl. S2","key":"10.1016\/j.cca.2025.120642_bb0115","first-page":"12","article-title":"Minimal residual disease in leukemia: state of the art 1991","volume":"6","author":"Hagenbeek","year":"1992","journal-title":"Leukemia"},{"issue":"4","key":"10.1016\/j.cca.2025.120642_bb0120","first-page":"1027","article-title":"Circulating tumour cells in diagnosis and treatment of lung Cancer","volume":"33","author":"Maly","year":"2019","journal-title":"In vivo (Athens, Greece)"},{"key":"10.1016\/j.cca.2025.120642_bb0125","author":"Lopresti","year":"2019","journal-title":"Sensitive and easy screening for circulating tumour cells by flow cytometry, JCI insight"},{"issue":"1","key":"10.1016\/j.cca.2025.120642_bb0130","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1186\/s13045-024-01637-3","article-title":"Dynamically monitoring minimal residual disease using circulating tumour cells to predict the recurrence of early-stage lung adenocarcinoma","volume":"17","author":"Zhang","year":"2024","journal-title":"J. Hematol. Oncol."},{"issue":"14","key":"10.1016\/j.cca.2025.120642_bb0135","doi-asserted-by":"crossref","first-page":"23130","DOI":"10.18632\/oncotarget.15506","article-title":"Circulating tumour cells in early-stage lung adenocarcinoma: a case series report and literature review","volume":"8","author":"Jin","year":"2017","journal-title":"Oncotarget"},{"issue":"168","key":"10.1016\/j.cca.2025.120642_bb0140","doi-asserted-by":"crossref","first-page":"20200065","DOI":"10.1098\/rsif.2020.0065","article-title":"Circulating tumour cells: a broad perspective","volume":"17","author":"Akpe","year":"2020","journal-title":"J. R. Soc. Interface"},{"key":"10.1016\/j.cca.2025.120642_bb0145","series-title":"the detection of epCAM+ and epCAM\u2013circulating tumour cells","author":"Leon","year":"2025"},{"issue":"1","key":"10.1016\/j.cca.2025.120642_bb0150","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2021.1938476","article-title":"Correlation between PD-L1 expression ON CTCs and prognosis of patients with cancer: a systematic review and meta-analysis","volume":"10","author":"Kong","year":"2021","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.cca.2025.120642_bb0155","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.lungcan.2016.07.021","article-title":"Monitoring KRAS mutations in circulating DNA and tumour cells using digital droplet PCR during treatment of KRAS-mutated lung adenocarcinoma","volume":"100","author":"Guibert","year":"2016","journal-title":"Lung Cancer"},{"key":"10.1016\/j.cca.2025.120642_bb0160","doi-asserted-by":"crossref","unstructured":"Y. Manjunath, S. V. Upparahalli, K. N. Suvilesh, D. M. Avella, E.T. Kimchi., K. F. Staveley-O'Carroll, G. Li, J. T. Kaifi, Circulating tumour cell clusters are a potential biomarker for detection of non-small cell lung cancer, Lung cancer. 134 (2019) 147\u2013150. doi:https:\/\/doi.org\/10.1016\/j.lungcan.2019.06.016.","DOI":"10.1016\/j.lungcan.2019.06.016"},{"issue":"1","key":"10.1016\/j.cca.2025.120642_bb0165","article-title":"Significance of CD44 and CD24 as cancer stem cell markers: an enduring ambiguity","volume":"2012","author":"Jaggupilli","year":"2012","journal-title":"J. Immunol. Res."},{"issue":"166","key":"10.1016\/j.cca.2025.120642_bb0170","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0151-2022","article-title":"Circulating tumour cells in patients with lung cancer universally indicate poor prognosis","volume":"31","author":"Jin","year":"2022","journal-title":"Eur. Respir. Rev."},{"key":"10.1016\/j.cca.2025.120642_bb0175","article-title":"Lung cancer proteomics: recent advances in biomarker discovery","volume":"1","author":"Indovina","year":"2011","journal-title":"Int. J. Proteom."},{"issue":"6","key":"10.1016\/j.cca.2025.120642_bb0180","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1158\/1078-0432.CCR-10-1363","article-title":"Immunobiomarkers in small cell lung cancer: potential early cancer signals","volume":"17","author":"Chapman","year":"2011","journal-title":"Clin. Cancer Res."},{"issue":"3","key":"10.1016\/j.cca.2025.120642_bb0185","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.lungcan.2007.07.002","article-title":"Serum Sialyl Lewis(x) and cytokeratin 19 fragment as predictive factors for recurrence in patients with stage I non-small cell lung cancer","volume":"58","author":"Mizuguchi","year":"2011","journal-title":"Lung Cancer"},{"issue":"3","key":"10.1016\/j.cca.2025.120642_bb0190","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1016\/j.athoracsur.2004.03.019","article-title":"Effect of histologic type and smoking status on interpretation of serum carcinoembryonic antigen value in non-small cell lung carcinoma","volume":"78","author":"Okada","year":"2004","journal-title":"Ann. Thorac. Surg."},{"issue":"21","key":"10.1016\/j.cca.2025.120642_bb0195","doi-asserted-by":"crossref","first-page":"9367","DOI":"10.7314\/APJCP.2014.15.21.9367","article-title":"Prediction of lung cancer based on serum biomarkers by gene expression programming methods","volume":"15","author":"Yu","year":"2014","journal-title":"Asian Pac. J. Cancer Prev."},{"issue":"35","key":"10.1016\/j.cca.2025.120642_bb0200","doi-asserted-by":"crossref","first-page":"5578","DOI":"10.1200\/JCO.2007.13.5392","article-title":"Panel of serum biomarkers for the diagnosis of lung cancer","volume":"25","author":"Patz","year":"2007","journal-title":"J. Clin. Oncol."},{"issue":"6","key":"10.1016\/j.cca.2025.120642_bb0205","doi-asserted-by":"crossref","first-page":"djv063","DOI":"10.1093\/jnci\/djv063","article-title":"miR-test: a blood test for lung cancer early detection","volume":"107","author":"Montani","year":"2015","journal-title":"J. Natl. Cancer Inst."},{"issue":"1","key":"10.1016\/j.cca.2025.120642_bb0210","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/JTO.0000000000000404","article-title":"Mucins in lung cancer diagnostic, prognostic, and therapeutic implications","volume":"10","author":"Lakshmanan","year":"2015","journal-title":"J. Thorac. Oncol."},{"issue":"4","key":"10.1016\/j.cca.2025.120642_bb0215","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1093\/ejcts\/ezw077","article-title":"Psf3 is a prognostic biomarker in lung adenocarcinoma: a larger trial using tissue microarrays of 864 consecutive resections","volume":"50","author":"Tauchi","year":"2016","journal-title":"Eur. J. Cardio Thorac. Surg."},{"key":"10.1016\/j.cca.2025.120642_bb0220","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.clinbiochem.2018.05.001","article-title":"Triple test with tumour markers CYFRA 21.1, HE4, and ProGRP might contribute to diagnosis and subtyping of lung cancer","volume":"58","author":"Korkmaz","year":"2018","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.cca.2025.120642_bb0225","doi-asserted-by":"crossref","first-page":"S81","DOI":"10.3233\/TUB-230021","article-title":"Improvement of differential diagnosis of lung cancer by use of multiple protein tumour marker combinations","volume":"46","author":"Trulson","year":"2024","journal-title":"Tumour Biol."},{"issue":"7","key":"10.1016\/j.cca.2025.120642_bb0230","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1038\/nm0795-701","article-title":"Serum p53 antibodies as early markers of lung cancer","volume":"1","author":"Lubin","year":"1995","journal-title":"Nat. Med."},{"issue":"6","key":"10.1016\/j.cca.2025.120642_bb0235","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1111\/crj.12769","article-title":"Significance of tumour-associated autoantibodies in the early diagnosis of lung cancer","volume":"12","author":"Du","year":"2018","journal-title":"Clin. Respir. J."},{"issue":"1","key":"10.1016\/j.cca.2025.120642_bb0240","doi-asserted-by":"crossref","DOI":"10.1080\/20013078.2018.1535750","article-title":"Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines","volume":"7","author":"Th\u00e9ry","year":"2018","journal-title":"J. Extracell. Vesicles"},{"issue":"10","key":"10.1016\/j.cca.2025.120642_bb0245","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1074\/mcp.R600001-MCP200","article-title":"The proteomic search for diagnostic biomarkers: lost in translation?","volume":"5","author":"Zolg","year":"2006","journal-title":"Mol. Cell. Proteomics"},{"key":"10.1016\/j.cca.2025.120642_bb0250","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1364473","article-title":"Biological insights from plasma proteomics of non-small cell lung cancer patients treated with immunotherapy","volume":"15","author":"Bar","year":"2024","journal-title":"Front. Immunol."},{"issue":"12","key":"10.1016\/j.cca.2025.120642_bb0255","doi-asserted-by":"crossref","first-page":"18901","DOI":"10.18632\/oncotarget.14782","article-title":"Identification of serum proteins and multivariate models for diagnosis and therapeutic monitoring of lung cancer","volume":"8","author":"Ma","year":"2017","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.cca.2025.120642_bb0260","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.70160","article-title":"LcProt: proteomics-based identification of plasma biomarkers for lung cancer multievent, a multicentre study","volume":"15","author":"Liang","year":"2025","journal-title":"Clin. Transl. Med."},{"issue":"1","key":"10.1016\/j.cca.2025.120642_bb0265","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.lungcan.2013.01.002","article-title":"Diagnostic value of CEA and CYFRA 21-1 tumour markers in primary lung cancer","volume":"80","author":"Okamur","year":"2013","journal-title":"Lung Cancer"},{"issue":"4","key":"10.1016\/j.cca.2025.120642_bb0270","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0095444","article-title":"Development of a multiplex autoantibody test for detection of lung cancer","volume":"9","author":"Jia","year":"2014","journal-title":"PloS One"},{"issue":"5","key":"10.1016\/j.cca.2025.120642_bb0275","doi-asserted-by":"crossref","first-page":"4901","DOI":"10.1007\/s13277-014-1643-4","article-title":"Detection of circulating antibodies to linear peptide antigens derived from ANXA1 and DDX53 in lung cancer","volume":"35","author":"Wang","year":"2014","journal-title":"Tumour Biol."},{"issue":"3","key":"10.1016\/j.cca.2025.120642_bb0280","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1007\/s13277-013-1271-4","article-title":"Autoantibodies against p16 protein-derived peptides may be a potential biomarker for non-small cell lung cancer","volume":"35","author":"Zhang","year":"2014","journal-title":"Tumour Biol."},{"issue":"7","key":"10.1016\/j.cca.2025.120642_bb0285","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1158\/1940-6207.CAPR-10-0328","article-title":"An early CDT-lung: an immunobiomarker test as an aid to early detection of lung cancer","volume":"4","author":"Lam","year":"2011","journal-title":"Cancer Prev. Res."},{"key":"10.1016\/j.cca.2025.120642_bb0290","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2407-10-234","article-title":"Identification of an autoantibody panel to separate lung cancer from smokers and nonsmokers","volume":"10","author":"Rom","year":"2010","journal-title":"BMC Cancer"},{"issue":"9","key":"10.1016\/j.cca.2025.120642_bb0295","first-page":"306","article-title":"Screening for lung cancer with the early CDT-lung and computed tomography","volume":"10","author":"Jett","year":"2015","journal-title":"J. Thorac. Oncol."},{"issue":"12","key":"10.1016\/j.cca.2025.120642_bb0300","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1038\/s41568-020-00299-w","article-title":"The evolving translational potential of small extracellular vesicles in cancer","volume":"20","author":"Moller","year":"2020","journal-title":"Nat. Rev. Cancer"},{"issue":"9","key":"10.1016\/j.cca.2025.120642_bb0305","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1016\/j.bbadis.2015.06.024","article-title":"Proteomics profiling of cholangiocarcinoma exosomes: a potential role of oncogenic protein transferring in cancer progression","volume":"1852","author":"Dutta","year":"2025","journal-title":"Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease"},{"issue":"6","key":"10.1016\/j.cca.2025.120642_bb0310","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.tcb.2015.01.004","article-title":"Ectosomes and exosomes: shedding the confusion between extracellular vesicles","volume":"25","author":"Cocucci","year":"2015","journal-title":"Trends Cell Biol."},{"issue":"3","key":"10.1016\/j.cca.2025.120642_bb0315","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.3390\/cimb46030142","article-title":"Autophagy-dependent secretion: crosstalk between autophagy and exosome biogenesis","volume":"46","author":"Zubkova","year":"2024","journal-title":"Curr. Issues Mol. Biol."},{"issue":"1","key":"10.1016\/j.cca.2025.120642_bb0320","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s12964-021-00730-1","article-title":"The exosome journey: from biogenesis to uptake and intracellular signalling","volume":"19","author":"Gurung","year":"2021","journal-title":"Cell Commun. Signal"},{"issue":"3","key":"10.1016\/j.cca.2025.120642_bb0325","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.devcel.2019.04.011","article-title":"Exosome-mediated metastasis communication from a distance","volume":"49","author":"Wortzel","year":"2019","journal-title":"Dev. Cell"},{"issue":"3","key":"10.1016\/j.cca.2025.120642_bb0330","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.3892\/ol.2017.5569","article-title":"Exosomal microRNA in plasma as a noninvasive biomarker for the recurrence of nonsmall cell lung cancer","volume":"13","author":"Dejima","year":"2017","journal-title":"Oncol. Lett."},{"issue":"1","key":"10.1016\/j.cca.2025.120642_bb0335","doi-asserted-by":"crossref","first-page":"123","DOI":"10.3390\/biomedicines12010123","article-title":"Extracellular vesicles and exosomes: novel insights and perspectives on lung cancer from early detection to targeted treatment","volume":"12","author":"Rahimian","year":"2024","journal-title":"Biomedicines"},{"issue":"11","key":"10.1016\/j.cca.2025.120642_bb0340","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1038\/nrc2947","article-title":"Rational, biologically based treatment of EGFR-mutant non-small-cell lung cancer","volume":"10","author":"Pao","year":"2010","journal-title":"Nat. Rev. Cancer"},{"issue":"1","key":"10.1016\/j.cca.2025.120642_bb0345","doi-asserted-by":"crossref","first-page":"17201","DOI":"10.1038\/s41598-022-22194-0","article-title":"Evaluation of circulating small extracellular vesicle-derived miRNAs as diagnostic biomarkers for differentiating between different pathological types of early lung cancer","volume":"12","author":"Jiang","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.cca.2025.120642_bb0350","first-page":"1608","article-title":"Exosome-derived miRNAs in liquid biopsy for","volume":"Life14 (12)","author":"Mart\u00ednez-Espinosa","year":"2024","journal-title":"Lung Cancer"},{"issue":"17","key":"10.1016\/j.cca.2025.120642_bb0355","doi-asserted-by":"crossref","first-page":"5311","DOI":"10.1158\/1078-0432.CCR-17-0577","article-title":"Evaluation of tumour-derived exosomal miRNA as potential diagnostic biomarkers for early-stage non\u2013small cell lung cancer using next-generation sequencing","volume":"23","author":"Jin","year":"2017","journal-title":"Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.cca.2025.120642_bb0360","first-page":"108","article-title":"Circulating nucleic acids are associated with outcomes of patients with pancreatic cancer","volume":"156","author":"Bernard","year":"2019","journal-title":"J. Gastroenterol."},{"issue":"7","key":"10.1016\/j.cca.2025.120642_bb0365","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1016\/j.bbagen.2012.03.017","article-title":"Exosomes: current knowledge of their composition, biological functions, and diagnostic and therapeutic potentials","volume":"1820","author":"Vlassov","year":"2017","journal-title":"Biochimica et Biophysica Acta (BBA)-General Subjects"},{"issue":"10","key":"10.1016\/j.cca.2025.120642_bb0370","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1158\/1541-7786.MCR-16-0044","article-title":"Cell-free DNA (cfDNA): clinical significance and utility in cancer shaped by emerging technologies","volume":"14","author":"Volik","year":"2016","journal-title":"Mol. Cancer Res."},{"issue":"3","key":"10.1016\/j.cca.2025.120642_bb0375","doi-asserted-by":"crossref","first-page":"732","DOI":"10.3390\/cancers14030732","article-title":"Exosomal proteins and lipids as potential biomarkers for lung cancer diagnosis, prognosis, and treatment","volume":"14","author":"Hsu","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.cca.2025.120642_bb0380","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.aca.2018.02.051","article-title":"Exosomal lipids for classifying early and late-stage non-small cell lung cancer","volume":"1037","author":"Fan","year":"2018","journal-title":"Anal. Chim. Acta"},{"issue":"1","key":"10.1016\/j.cca.2025.120642_bb0385","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1186\/s12967-024-05215-6","article-title":"Exosome-transported circ_0061407 and circ_0008103 play a tumour-repressive role and show diagnostic value in non-small-cell lung cancer","volume":"22","author":"Chen","year":"2024","journal-title":"J. Transl. Med."},{"issue":"11","key":"10.1016\/j.cca.2025.120642_bb0390","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1097\/JTO.0000000000000334","article-title":"Advisory Board Members and Participating Institutions, The IASLC lung cancer staging project: the new database to inform the eighth edition of the TNM classification of lung cancer","volume":"9","author":"Rami-Porta","year":"2014","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.cca.2025.120642_bb0395","doi-asserted-by":"crossref","DOI":"10.1016\/j.meomic.2024.100039","article-title":"The omics technologies and liquid biopsies: Advantages, limitations, applications","author":"Magro","year":"2024","journal-title":"Medicine in Omics"},{"issue":"7","key":"10.1016\/j.cca.2025.120642_bb0400","first-page":"1601","article-title":"Early diagnostic and prognostic value of serum exosomal miR-1246 in non-small cell lung cancer","volume":"13","author":"Huang","year":"2020","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"10.1016\/j.cca.2025.120642_bb0405","article-title":"Identification of circulating miR-762 as a novel diagnostic and prognostic biomarker for non-small cell lung cancer","volume":"19","author":"Chen","year":"2020","journal-title":"TCRT"},{"issue":"6","key":"10.1016\/j.cca.2025.120642_bb0410","doi-asserted-by":"crossref","first-page":"4866","DOI":"10.18632\/aging.102908","article-title":"MiR-519d targets HER3 and can be used as a potential serum biomarker for non-small cell lung cancer","volume":"12","author":"Wang","year":"2020","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.cca.2025.120642_bb0415","article-title":"Tumour-derived exosomal miRNAs as diagnostic biomarkers in non-small cell lung cancer","volume":"10","author":"Zhang","year":"2020","journal-title":"Front. Oncol."},{"key":"10.1016\/j.cca.2025.120642_bb0420","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2020.597508","article-title":"Serum MiR-4687-3p has potential for diagnosis and carcinogenesis in non-small cell lung cancer","volume":"11","author":"Liu","year":"2020","journal-title":"Front. Genet."},{"issue":"4","key":"10.1016\/j.cca.2025.120642_bb0425","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1177\/1724600820967124","article-title":"Circulating microRNA-145 as a diagnostic biomarker for non-small-cell lung cancer: a systemic review and meta-analysis","volume":"35","author":"Tao","year":"2020","journal-title":"Int. J. Biol. Marker."},{"issue":"4","key":"10.1016\/j.cca.2025.120642_bb0430","doi-asserted-by":"crossref","DOI":"10.1016\/j.currproblcancer.2020.100540","article-title":"Identification of differentially expressed circulating serum microRNA for the diagnosis and prognosis of Indian non\u2013small cell lung cancer patients","volume":"44","author":"Kumar","year":"2020","journal-title":"Curr. Probl. Cancer"},{"issue":"6","key":"10.1016\/j.cca.2025.120642_bb0435","doi-asserted-by":"crossref","DOI":"10.1002\/jcla.23237","article-title":"Serum exosomal miR-378 upregulation is associated with poor prognosis in non\u2013small-cell lung cancer patients","volume":"34","author":"Zhang","year":"2020","journal-title":"J. Clin. Lab. Anal."},{"issue":"2","key":"10.1016\/j.cca.2025.120642_bb0440","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1080\/15384047.2021.1872155","article-title":"Evaluation of microRNAs as potential biomarkers in circulating HPV-DNA-positive non-small cell lung cancer patients","volume":"22","author":"Wu","year":"2021","journal-title":"Cancer Biol. Ther."},{"issue":"5","key":"10.1016\/j.cca.2025.120642_bb0445","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3892\/ol.2021.13053","article-title":"Four plasma miRNAs act as biomarkers for diagnosis and prognosis of non-small cell lung cancer","volume":"22","author":"Jiang","year":"2021","journal-title":"Oncol. Lett."},{"issue":"3","key":"10.1016\/j.cca.2025.120642_bb0450","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1111\/cas.14199","article-title":"Circulating micro-RNA-590-5p functions as a liquid biopsy marker in non-small cell lung cancer","volume":"111","author":"Khandelwal","year":"2020","journal-title":"Cancer Sci."},{"issue":"1","key":"10.1016\/j.cca.2025.120642_bb0455","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/jitc-2019-000376","article-title":"Correlation of plasma exosomal microRNAs with the efficacy of immunotherapy in EGFR\/ALK wild-type advanced non-small cell lung cancer","volume":"8","author":"Peng","year":"2020","journal-title":"J. Immunother. Cancer"},{"issue":"1","key":"10.1016\/j.cca.2025.120642_bb0460","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12957-021-02376-2","article-title":"The expression of miRNA216b is negatively correlated with 18F-FDG uptake in non-small cell lung cancer","volume":"19","author":"Zuo","year":"2021","journal-title":"World J. Surg. Oncol."},{"issue":"12","key":"10.1016\/j.cca.2025.120642_bb0465","doi-asserted-by":"crossref","first-page":"2056","DOI":"10.3390\/jpm12122056","article-title":"Identification of potential microRNA panels for male non-small cell lung cancer identification using microarray datasets and bioinformatics methods","volume":"12","author":"Harangu\u015f","year":"2022","journal-title":"J. Pers. Med."},{"issue":"14","key":"10.1016\/j.cca.2025.120642_bb0470","doi-asserted-by":"crossref","first-page":"3412","DOI":"10.3390\/cancers14143412","article-title":"A circulating risk score, based on combined expression of exo-miR-130a-3p and fibrinopeptide a, as predictive biomarker of relapse in resectable non-small cell lung cancer patients","volume":"14","author":"Marconi","year":"2022","journal-title":"Cancers"},{"issue":"10","key":"10.1016\/j.cca.2025.120642_bb0475","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.3390\/cancers14102435","article-title":"Large-scale profiling of extracellular vesicles identified miR-625-5p as a novel biomarker of immunotherapy response in advanced non-small-cell lung cancer patients","volume":"14","author":"Pantano","year":"2022","journal-title":"Cancers"},{"issue":"12","key":"10.1016\/j.cca.2025.120642_bb0480","doi-asserted-by":"crossref","first-page":"2944","DOI":"10.1158\/1078-0432.CCR-17-3369","article-title":"Exosome-based detection of EGFR T790M in plasma from non\u2013small cell lung cancer patients","volume":"24","author":"Castellanos-Rizaldos","year":"2018","journal-title":"Clin. Cancer Res."},{"issue":"14","key":"10.1016\/j.cca.2025.120642_bb0485","doi-asserted-by":"crossref","first-page":"3414","DOI":"10.3390\/cancers13143414","article-title":"The lipid composition of serum-derived small extracellular vesicles in participants of a lung cancer screening study","volume":"13","author":"Smolarz","year":"2021","journal-title":"Cancers"},{"issue":"4","key":"10.1016\/j.cca.2025.120642_bb0490","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1038\/s44321-024-00052-y","article-title":"Lipidomics reveals new lipid-based lung adenocarcinoma early diagnosis model","volume":"16","author":"Sun","year":"2024","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.cca.2025.120642_bb0495","first-page":"1","article-title":"A review of metabolism-associated biomarkers in lung cancer diagnosis and treatment","volume":"14","author":"Bamji-Stocke","year":"2018","journal-title":"J. Metabolomics"},{"issue":"1","key":"10.1016\/j.cca.2025.120642_bb0500","first-page":"188","article-title":"Targeted metabolomics for serum amino acids and acylcarnitines in patients with lung cancer","volume":"18","author":"Ni","year":"2019","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.cca.2025.120642_bb0505","article-title":"Lung cancer scRNA-seq and lipidomics reveal aberrant lipid metabolism for early-stage diagnosis","volume":"14 (630), eabk2756","author":"Wang","year":"2022","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.cca.2025.120642_bb0510","first-page":"1","article-title":"Temporal characterization of serum metabolite signatures in lung cancer patients undergoing treatment","volume":"12","author":"Hao","year":"2016","journal-title":"J. Metabolomics"},{"issue":"1","key":"10.1016\/j.cca.2025.120642_bb0515","doi-asserted-by":"crossref","first-page":"11805","DOI":"10.1038\/s41598-021-91276-2","article-title":"High-resolution metabolomic biomarkers for lung cancer diagnosis and prognosis","volume":"11","author":"Qi","year":"2021","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.cca.2025.120642_bb0520","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12885-023-11764-8","article-title":"Exploring the role of ELOVLs family in lung adenocarcinoma based on bioinformatic analysis and experimental validation","volume":"25","author":"Wang","year":"2025","journal-title":"BMC Cancer"},{"key":"10.1016\/j.cca.2025.120642_bb0525","article-title":"Comprehensive analysis of a novel signature incorporating lipid metabolism and immune-related genes for assessing prognosis and immune landscape in lung adenocarcinoma","volume":"13","author":"Wang","year":"2022","journal-title":"Front. Immunol."},{"issue":"3","key":"10.1016\/j.cca.2025.120642_bb0530","doi-asserted-by":"crossref","first-page":"513","DOI":"10.18388\/abp.2017_1517","article-title":"Panel of serum metabolites discriminates cancer patients and healthy participants of lung cancer screening-a pilot study","volume":"64","author":"Ro\u015b-Mazurczyk","year":"2017","journal-title":"Acta Biochim. Pol."},{"key":"10.1016\/j.cca.2025.120642_bb0535","first-page":"2682","article-title":"Metabolomic-based biomarker discovery for non-invasive lung cancer screening: a case study","volume":"11","author":"O'Shea","year":"1860","journal-title":"Biochimica et Biophysica Acta (BBA)-General Subjects"},{"issue":"11","key":"10.1016\/j.cca.2025.120642_bb0540","doi-asserted-by":"crossref","first-page":"12904","DOI":"10.18632\/oncotarget.7354","article-title":"Serum metabolomic profiling facilitates the non-invasive identification of metabolic biomarkers associated with the onset and progression of non-small cell lung cancer","volume":"7","author":"Puchades-Carrasco","year":"2016","journal-title":"Oncotarget"},{"issue":"2","key":"10.1016\/j.cca.2025.120642_bb0545","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1111\/cas.15629","article-title":"Serum untargeted metabolomics reveal metabolic alteration of non-small cell lung cancer and refine disease detection","volume":"114","author":"Li","year":"2023","journal-title":"Cancer Sci."},{"key":"10.1016\/j.cca.2025.120642_bb0550","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.jpba.2018.02.051","article-title":"Prediction of platinum-based chemotherapy efficacy in lung cancer based on LC\u2013MS metabolomics approach","volume":"154","author":"Peng","year":"2018","journal-title":"J. Pharm. Biomed. Anal."},{"issue":"7","key":"10.1016\/j.cca.2025.120642_bb0555","doi-asserted-by":"crossref","first-page":"3444","DOI":"10.1021\/acs.jproteome.0c01019","article-title":"Combined metabolomics with transcriptomics reveals important serum biomarkers correlated with lung cancer proliferation through a calcium signaling pathway","volume":"20","author":"Zheng","year":"2021","journal-title":"J. Proteome Res."},{"issue":"5","key":"10.1016\/j.cca.2025.120642_bb0560","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0232272","article-title":"A comprehensive analysis of metabolomics and transcriptomics in non-small cell lung cancer","volume":"15","author":"Ruiying","year":"2020","journal-title":"PloS One"},{"issue":"18","key":"10.1016\/j.cca.2025.120642_bb0565","doi-asserted-by":"crossref","first-page":"4556","DOI":"10.3390\/cancers15184556","article-title":"Enhancing lung cancer classification through integration of liquid biopsy multi-omics data with machine learning techniques","volume":"15","author":"Kwon","year":"2023","journal-title":"Cancers"},{"issue":"19","key":"10.1016\/j.cca.2025.120642_bb0570","doi-asserted-by":"crossref","first-page":"3165","DOI":"10.3390\/cancers17193165","article-title":"Artificial intelligence-enhanced liquid biopsy and Radiomics in early-stage lung Cancer detection: a precision oncology paradigm","volume":"17","author":"Cherukuri","year":"2025","journal-title":"Cancers"},{"issue":"3","key":"10.1016\/j.cca.2025.120642_bb0575","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3390\/arm93030017","article-title":"Clinical utility of ctDNA analysis in lung Cancer\u2014a review","volume":"93","author":"Makar","year":"2025","journal-title":"Advances in Respiratory Medicine"},{"issue":"19","key":"10.1016\/j.cca.2025.120642_bb0580","article-title":"Comparison of value of biomarkers in diagnosing lung cancer: an overview of systematic reviews protocol","volume":"98","author":"Wu, F., Wang, H., Tao, H., Huang, H., Zhang, L., Wu, D., Wan, Y., & Cancer Biomarker Assessment Working Group","year":"2019","journal-title":"Medicine"},{"issue":"4","key":"10.1016\/j.cca.2025.120642_bb0585","doi-asserted-by":"crossref","first-page":"LMT40","DOI":"10.2217\/lmt-2020-0022","article-title":"Biopsy frequency and complications among lung cancer patients in the United States","volume":"9","author":"Zhang","year":"2020","journal-title":"Lung cancer management"},{"key":"10.1016\/j.cca.2025.120642_bb0590","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2023.1152470","article-title":"Enhancing clinical potential of liquid biopsy through a multi-omic approach: a systematic review","volume":"14","author":"Di Sario","year":"2023","journal-title":"Front. Genet."},{"issue":"4","key":"10.1016\/j.cca.2025.120642_bb0595","doi-asserted-by":"crossref","first-page":"420","DOI":"10.21037\/tlcr.2016.08.06","article-title":"Pros: can tissue biopsy be replaced by liquid biopsy?","volume":"5","author":"Ili\u00e9","year":"2016","journal-title":"Translational lung cancer research"},{"key":"10.1016\/j.cca.2025.120642_bb0600","doi-asserted-by":"crossref","DOI":"10.3389\/or.2024.1445826","article-title":"Biomarker testing in lung cancer: from bench to bedside","volume":"18","author":"Batra","year":"2025","journal-title":"Oncol. Rev."},{"issue":"8","key":"10.1016\/j.cca.2025.120642_bb0605","doi-asserted-by":"crossref","first-page":"962","DOI":"10.3390\/genes16080962","article-title":"Genomics in lung Cancer: a scoping review of the role of ctDNA in non-advanced non-small-cell lung Cancer in the prediction of prognosis after multimodality therapeutic approaches","volume":"16","author":"Sassorossi","year":"2025","journal-title":"Genes"},{"key":"10.1016\/j.cca.2025.120642_bb0610","article-title":"Research progress of CTC, ctDNA, and EVs in cancer liquid biopsy","volume":"14","author":"Wang","year":"2024","journal-title":"Front. Oncol."},{"issue":"21","key":"10.1016\/j.cca.2025.120642_bb0615","doi-asserted-by":"crossref","first-page":"6384","DOI":"10.1158\/0008-5472.CAN-13-2030","article-title":"Real-time liquid biopsy in Cancer patients: fact or fiction?","volume":"73","author":"Pantel","year":"2013","journal-title":"Cancer Res."},{"issue":"6","key":"10.1016\/j.cca.2025.120642_bb0620","doi-asserted-by":"crossref","first-page":"428","DOI":"10.3390\/cimb47060428","article-title":"Revolution of circulating tumor DNA: from bench innovations to bedside implementations","volume":"47","author":"Yan","year":"2025","journal-title":"Curr. Issues Mol. Biol."},{"issue":"10","key":"10.1016\/j.cca.2025.120642_bb0625","doi-asserted-by":"crossref","first-page":"4519","DOI":"10.3390\/ijms26104519","article-title":"Clinical validation of plasma metabolite markers for early lung Cancer detection","volume":"26","author":"Zhang","year":"2025","journal-title":"Int. J. Mol. Sci."}],"container-title":["Clinica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898125005212?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898125005212?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T12:35:53Z","timestamp":1777379753000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009898125005212"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":125,"alternative-id":["S0009898125005212"],"URL":"https:\/\/doi.org\/10.1016\/j.cca.2025.120642","relation":{},"ISSN":["0009-8981"],"issn-type":[{"value":"0009-8981","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Non-nucleic acid biomarkers in early detection of lung cancer","name":"articletitle","label":"Article Title"},{"value":"Clinica Chimica Acta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cca.2025.120642","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"120642"}}